Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
PR Newswire

News of the day

Spherics, Inc. Offers Extended Release Formulation for Sustained and Stable Levodopa Levels

25th August 2008 WELLESLEY HILLS, Massachusetts, August 25 /PRNewswire/ -- Joseph F. Finn, Jr., C.P.A. ("Finn"), Assignee of the assets of Spherics, Inc. ("Spherics") for the benefit of creditors, announced today that all pharmaceutical intellectual property will be sold at a sealed bid auction on October 10, 2008. SRx-501 is an extended release formulation of Levodopa-Carbidopa that is the current gold standard treatment for Parkinson's disease, with global sales estimated at approximately US$250 million.... more

ESBATech Raises Additional CHF 23M (USD 22M), Extending Series B Venture Financing

7th August 2008 ZURICH, Switzerland, August 7 /PRNewswire/ -- ESBATech AG, a leading developer of antibody fragment therapeutics, today announced that the company has raised an additional CHF 23M (USD 22M, EUR 14M) in an extended Series B venture round to expand its development pipeline. A global syndicate of current investors participated in this round including SV Life Sciences, Clarus Ventures, HBM BioVentures, HBM BioCapital, Novartis Bioventures, BioMedinvest and VI Partners. This funding builds on... more

Launch of Fountain Healthcare Partners, a Life Science Venture Capital Firm

29th April 2008 DUBLIN and NEW YORK, April 29 /PRNewswire/ -- Fountain Healthcare Partners ("Fountain") today launches and announces the first close of its inaugural fund, Fountain Healthcare Partners I, with EUR75 (US$117) million of committed capital. The fund is the largest dedicated life science (specialty pharmaceuticals, biotechnology, medical devices and diagnostics) venture capital ("VC") firm based in Ireland. It is also one of the largest emerging manager VC funds raised in the life science... more
Venture Capital RSS feed

PR Newswire search

Search the PR Newswire by keyword. Alternatively our advanced search allows you to query by category.
Category
To choose more then one item on the list hold CTRL button while selecting. To deselect items press CTRL button and deselect.

More recent news

Breathe Technologies, Inc. Closes on US$15 Million in Venture Funding Led by Kleiner Perkins Caufield & Byers
26th March 2008 FREMONT, California, March 26 /PRNewswire/ -- Breathe Technologies, Inc., which is developing innovative, patient-friendly medical devices to treat respiratory problems associated with Chronic...

Partnering consultation free of charge
Leksir Ltd
Yissum Technology Transfer Hebrew University
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us